2012 International Plasma Protein Congress

Supply Data

The Source

 
Welcome to PPTA

The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world’s leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics.

The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficiency, burns and shock.

As the global representative for the plasma collection and therapeutics industry, PPTA works cooperatively with patient groups, policymakers, regulatory agencies and other stakeholders to address critical issues.

en Español

 
NEW! Becoming a Plasma Donor [Watch video]

Learn About Becoming a Plasma Donor

PPTA Letter to Stakeholders re: North America Data Program (Nov 15, 2011)
PPTA is implementing modifications to the data program, the most notable of which is the move from a one-month reporting lag to a three-month reporting lag. Product supply data reported by participating manufacturers in October 2011 will be reported on PPTA’s Web site in early February 2012. This change is effective immediately. PPTA’s commitment to shortage preparedness-related supply data reporting remains firm. We believe these changes will make the North America data program even stronger and more useful to stakeholders.  Read More
California State Assemblymember Atkins Honored At PPTA's Business Forum
ANNAPOLIS, MD (October 27, 2011) The Plasma Protein Therapeutics Association (PPTA) honored California State Assemblymember Toni Atkins (D) of San Diego as State Legislator of the Year for 2011-2012. Assemblymember Atkins received the award at the 2011 PPTA Source Business Forum taking place earlier this week in San Diego, California.  Read More
PPTA Attends FDA Public Workshop on Drug Shortages
ANNAPOLIS, MD (September 27, 2011) The Plasma Protein Therapeutics Association (PPTA) attended a U.S. Food and Drug Administration (FDA)–sponsored workshop to address growing concerns regarding drug shortages in certain sectors of the pharmaceutical industry September 26. The workshop convened a diverse group of stakeholders including manufacturers, wholesalers, patients, physicians, regulators and policymakers to address the causes of drug shortages and potential responses. FDA staff expressed an interest in timely, bi-directional communications with stakeholders.   Read More
HOMECONTACTNEWSROOMSITE MAPTERMS OF USEPRIVACY POLICY